key: cord-0903030-zbr3m3zr authors: Chotalia, Minesh; Ali, Muzzammil; Alderman, Joseph; Kalla, Manish; Parekh, Dhruv; Bangash, Mansoor; Patel, Jaimin title: The authors reply date: 2022-01-28 journal: Crit Care Med DOI: 10.1097/ccm.0000000000005453 sha: 73b8e56f0d86a364f26d8fc74739d1b64272eb92 doc_id: 903030 cord_uid: zbr3m3zr nan T he recently published article by Lee et al (1) reported that preexisting clinical frailty was associated with worse outcomes in patients with sepsis. The authors demonstrated how frailty affected the outcome in patients with sepsis by carefully adjusting for background factors using propensity score matching. We would like to discuss how we should use their findings for sepsis in clinical practice. Interestingly, they showed that inappropriate administration of antibiotics was more common in their frail group than in their nonfrail group. The latest Surviving Sepsis Campaign guidelines recommend empiric antimicrobials for coverage of methicillin-resistant Staphylococcus aureus or two antimicrobials for Gram-negative coverage, based on risk factors such as past bacteriological information and treatment history (2) . It is unclear whether the results by Lee et al (1) are due to repeated antibiotic exposures. However, because past medical information is often difficult to obtain accurately in emergency departments, frailty may be a new indicator for use of broad-spectrum antibiotics. Their findings will also be useful in shared decision-making for patients with sepsis. However, we should interpret their finding carefully because some frail patients might have opted for limited treatment, such as via a do-not-intubate (DNI) order and limitations on treatment can affect outcome. Etiopathogenetic Particularities and Prognostic Impact of Right Ventricular Involvement in COVID-19-Related Acute Respiratory Distress Syndrome Right ventricular dysfunction and its association with mortality in coronavirus disease 2019 acute respiratory distress syndrome Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS The authors reply Protecting the Right Ventricle Network: The right ventricle in COVID-19 lung injury: Proposed mechanisms, management, and research gaps